Annual cervical cancer screening with Papanicolaou (Pap) and human papillomavirus
(HPV) testing after stem cell transplant (SCT) is recommended, but the uptake is unknown …

Human papillomavirus (HPV) infection is widespread throughout the general population,
most commonly causing cutaneous and anogenital warts. Oral and respiratory tract HPV …

Background This study aimed to analyze the relationship between the several risk factors for
human papillomavirus (HPV) infection and its persistence and to assess the prevalence of …

Organ transplant recipients (OTR) are at increased risk of cutaneous squamous cell
carcinoma, which may be related to reactivation of human papillomavirus (HPV) infections …

Survivors of childhood cancer and other immunocompromised children are at high risk for
the development of secondary human papillomavirus (HPV)–associated cancers. In this …

Risks of secondary solid cancers among allogeneic hematopoietic cell transplant (HCT)
recipients who receive conditioning without total body irradiation are not well known. We …

Background Despite intensive study of high-risk mucosal human papillomaviruses (HPV),
little is known of the epidemiology of cutaneous HPV. As part of a study of cutaneous …

Solid organ transplant (SOT) recipients have an approximately 2-fold greater risk of
developing and dying from a malignancy compared to the general population. Among the …

In this registry‐based cohort study, we estimated the risk of human papillomavirus (HPV)‐
related anogenital premalignancies and cancer in renal transplant recipients (RTRs) …

Supplement to Transplantation July 27, 2008, Volume 86 Number 2S stomach cancer (n=
22, 11.6%), colorectal cancer (n= 22, 11.6%), urologic cancer (n= 19, 10.0%) …